Agenus (AGEN) Cash from Financing Activities (2010 - 2026)

Agenus' (AGEN) quarterly Cash from Financing Activities came in at -$993000.0 in Q1 2026, down 127.63% year-on-year from $3.6 million in Q1 2025, and down 106.46% quarter-over-quarter from $15.4 million in Q4 2025.

Agenus (AGEN) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Agenus' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$993000.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 127.63% year-over-year to -$993000.0 in Q1 2026; TTM through Mar 2026 was $32.0 million, a 71.32% decrease from a year earlier, with the FY2025 full-year figure at $36.6 million, down 70.21% from the prior year.
  • Cash from Financing Activities retreated to -$993000.0 in Q1 2026 per AGEN's latest filing, from $15.4 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $79.1 million in Q2 2024 and bottomed at -$993000.0 in Q1 2026.
  • The 5-year median for Cash from Financing Activities is $16.0 million (2022), against an average of $22.0 million.
  • Across the five-year window, Cash from Financing Activities jumped 250.73% in 2023 and slumped 127.63% in 2026, its largest moves.
  • Year by year, Cash from Financing Activities stood at $23.8 million in 2022, then tumbled by 69.23% to $7.3 million in 2023, then soared by 233.15% to $24.4 million in 2024, then plunged by 36.91% to $15.4 million in 2025, then sank by 106.46% to -$993000.0 in 2026.
  • Per Business Quant, the three latest AGEN Cash from Financing Activities figures stand at -$993000.0 (Q1 2026), $15.4 million (Q4 2025), and $6.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Agenus 184.05 Mn 177.29 Mn 33.74 Mn -993,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -993,000.00
Mar 31, 2026 -993,000.00
Dec 31, 2025 15.37 Mn
Dec 31, 2025 15.37 Mn
Sep 30, 2025 6.68 Mn
Sep 30, 2025 6.68 Mn
Jun 30, 2025 10.94 Mn
Jun 30, 2025 10.94 Mn
Mar 31, 2025 3.59 Mn
Mar 31, 2025 3.59 Mn
Dec 31, 2024 24.37 Mn
Dec 31, 2024 24.37 Mn
Sep 30, 2024 4.56 Mn
Sep 30, 2024 4.56 Mn
Jun 30, 2024 79.08 Mn
Jun 30, 2024 79.08 Mn
Mar 31, 2024 14.83 Mn
Mar 31, 2024 14.83 Mn
Dec 31, 2023 7.32 Mn
Dec 31, 2023 7.32 Mn